CVIR Endovascular (May 2024)

Transfemoral hepatic vein catheterization reduces procedure time in double vein embolization

  • Dominik A. Steffen,
  • Arash Najafi,
  • Christoph A. Binkert

DOI
https://doi.org/10.1186/s42155-024-00463-5
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 5

Abstract

Read online

Abstract Background Double vein embolization with simultaneous embolization of the portal and hepatic vein aims to grow the future liver remnant in preparation for major hepatectomy. Transvenous hepatic vein embolization is usually done via a transjugular access. The purpose of this study is to describe the transfemoral approach as an alternative option and to discuss potential advantages. Results Twenty-three patients undergoing hepatic vein embolization via a transjugular (n = 10) or transfemoral access (n = 13) were evaluated retrospectively. In all cases the portal vein embolization was done first. All procedures were technically successful. There were no peri-interventional complications. Only two patients were not able to proceed to surgery. Standardized future liver remnant hypertrophy was non-inferior with the transfemoral approach compared to the transjugular route. Procedure time was significantly shorter in the transfemoral access group (40 ± 13 min) compared to the transjugular group (67 ± 13 min, p < 0.001). Conclusion Transfemoral hepatic vein embolization is feasible, safe, and faster due to easier catheterization, improved stability, and simpler patient preparation. These findings will need to be validated in larger studies.

Keywords